GCC Countries Allergy Diagnostics Market (2026-2031)
The GCC Countries Allergy Diagnostics Market was valued at $123.5 Million in 2026 and projected to reach to $203.8 Million by 2031, representing a compound annual growth rate of 10.5%. The GCC allergy diagnostics market is positioned for substantial growth through 2031, supported by increasing healthcare expenditure and modernization initiatives across Saudi Arabia, UAE, and other Gulf states.
GCC Countries Allergy Diagnostics Market Trends and Insights
- Middle East & Africa is witnessing accelerating demand for allergy testing solutions driven by rising prevalence of allergic diseases, increasing healthcare infrastructure investment, and growing awareness of diagnostic precision.
- The region's market growth outpaces the global average, reflecting expanding middle-class populations and enhanced access to modern diagnostic technologies across both developed and emerging healthcare systems in Middle East & Africa. Middle East & Africa's allergy diagnostics sector is characterized by rising adoption of in vitro and molecular testing methods, supported by regulatory improvements and private healthcare expansion.
- Middle East & Africa markets are increasingly integrating advanced immunoassay platforms and component-resolved diagnostics to address the region's specific allergen profiles.
- The forecast period through 2031 indicates sustained momentum in Middle East & Africa, with healthcare providers prioritizing early diagnosis and personalized allergy management strategies to improve patient outcomes..
Key Market Statistics
- CAGR (2026-2031) 10.5% CAGR
- Market Size, 2026 ~USD 123.5 Million
- Forecast, 2031 ~USD 203.8 Million
- Country GCC Countries
GCC Countries Allergy Diagnostics Market Overview
Market Valuation Growth :
GCC allergy diagnostics market valued at USD 123.5 million in 2026, expanding to USD 203.8 million by 2031, representing a robust 10.5% CAGR driven by regional healthcare modernization.
Rising Allergic Disease Prevalence :
GCC countries experiencing significant increase in allergic conditions due to environmental factors, urbanization, and lifestyle changes, creating sustained demand for advanced diagnostic solutions.
Healthcare Infrastructure Investment :
Gulf nations investing heavily in healthcare facilities and diagnostic capabilities, with government initiatives supporting adoption of precision allergy testing technologies across public and private sectors.
Diagnostic Precision Awareness :
Growing physician and patient awareness in GCC markets regarding benefits of accurate allergy diagnostics, driving shift from symptomatic treatment to evidence-based diagnostic approaches.
GCC Countries Allergy Diagnostics Market Dynamics
- Rising prevalence of allergic diseases, coupled with enhanced diagnostic awareness among healthcare providers and patients, is accelerating market expansion.
- Government healthcare reforms and private sector investments are strengthening diagnostic infrastructure, enabling wider adoption of advanced allergy testing solutions. Regional players and international diagnostics companies are capitalizing on GCC market opportunities through strategic partnerships and localized offerings.
- The market's outperformance relative to global growth rates reflects the region's commitment to healthcare excellence and precision medicine adoption.
- Continued economic diversification and healthcare sector development will sustain momentum, positioning GCC as a high-growth market for allergy diagnostics through the forecast period..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Middle East & Africa allergy diagnostics market valued at USD 123.5 million in 2026, expanding to USD 203.8 million by 2031 at 10.5% CAGR
- Middle East & Africa demonstrates faster growth than global average, driven by rising allergic disease prevalence and healthcare infrastructure modernization
- In vitro and molecular diagnostic methods are gaining traction across Middle East & Africa as providers adopt precision allergy testing
- Middle East & Africa's private healthcare sector and expanding middle-class populations are key catalysts for sustained market expansion through 2031
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
GCC Countries Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Equipment Manufacturers : Require GCC-specific market data to develop localized product strategies, establish distribution networks, and capitalize on growing demand for allergy testing technologies in Gulf healthcare facilities.
- Healthcare Investment Firms : Need detailed GCC market analysis to evaluate investment opportunities in diagnostic companies, healthcare infrastructure projects, and emerging players in the regional allergy diagnostics sector.
- Hospital & Clinic Operators : Seek market insights to justify diagnostic service expansion, benchmark against regional peers, and align allergy testing capabilities with growing patient demand across GCC nations.
- Pharmaceutical & Biotech Companies : Require GCC market intelligence to support companion diagnostic development, clinical trial planning, and market access strategies for allergy-related therapeutics in Gulf regions.
- Healthcare Consultants & Advisors : Need comprehensive GCC market data to advise clients on market entry strategies, competitive positioning, and growth opportunities within the region's expanding allergy diagnostics sector.
Key Companies in the GCC Countries Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- GCC-Specific Market Sizing : Obtain precise market valuation and forecast data exclusive to GCC countries, enabling accurate investment planning and resource allocation for regional expansion strategies.
- Regional Growth Trajectory Analysis : Understand the 10.5% CAGR dynamics specific to GCC markets, identifying growth drivers and market acceleration patterns unique to Gulf healthcare ecosystems.
- Competitive Landscape Intelligence : Gain insights into GCC-specific competitive positioning, local player strategies, and market entry opportunities tailored to individual Gulf nation healthcare systems.
- Healthcare Infrastructure Insights : Access detailed analysis of GCC healthcare investment trends, diagnostic facility development, and government initiatives shaping allergy diagnostics adoption across the region.
- Strategic Market Opportunity Identification : Identify high-potential segments and geographic pockets within GCC countries for targeted product launches, partnerships, and market penetration strategies.
Frequently asked questions
What is the current market size of allergy diagnostics in Middle East & Africa?
The Middle East & Africa allergy diagnostics market is valued at USD 123.5 million in 2026 and is projected to grow to USD 203.8 million by 2031.
What is the expected growth rate for allergy diagnostics in Middle East & Africa?
Middle East & Africa's allergy diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 10.5% from 2026 to 2031.
What factors are driving growth in the Middle East & Africa allergy diagnostics market?
Key drivers include rising prevalence of allergic diseases, increased healthcare infrastructure investment, growing diagnostic awareness, expanding private healthcare sectors, and rising middle-class populations across Middle East & Africa.
Which diagnostic technologies are gaining adoption in Middle East & Africa?
Middle East & Africa is increasingly adopting in vitro testing, molecular diagnostics, advanced immunoassay platforms, and component-resolved diagnostics to address region-specific allergen profiles.
How does Middle East & Africa's market growth compare to global trends?
Middle East & Africa's allergy diagnostics market is growing faster than the global average of 9.6% CAGR, with the region achieving 10.5% CAGR, reflecting stronger regional demand and healthcare modernization.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report